-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Symposium for Mid-Career Hematologists

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Fundamental Science, Translational Research, Clinical Research, Workforce
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Room 24 (San Diego Convention Center)
Chairs:
Juan Pablo Alderuccio, MD, Sylvester Comprehensive Cancer Center University of Miami and Shruti Chaturvedi, MBBS, Johns Hopkins University
Disclosures:
Alderuccio: Regeneron: Consultancy; Genmab: Research Funding; BeiGene: Research Funding; AbbVie: Consultancy; ADC Therapeutics: Consultancy, Research Funding; Genentech: Consultancy. Chaturvedi: Takeda: Consultancy, Membership on an entity's Board of Directors or advisory committees; Sanofi: Consultancy, Membership on an entity's Board of Directors or advisory committees; Alexion, AstraZeneca Rare Disease: Consultancy, Membership on an entity's Board of Directors or advisory committees; SOBI: Consultancy, Membership on an entity's Board of Directors or advisory committees.

This symposium aims to guide the audience through the common challenges faced by mid-career hematologists. Some examples of unique challenges for mid-career hematologists include negotiating the first leadership position, principles of leadership, promotion, strategies for managing individuals and teams, conflict management, setting up a successful research program, time management, funding beyond career development awards, performance and compensation metrics, self-care and opportunities to contribute to the Society’s mission. Speakers will include a diverse pool of successful physicians and scientists from academia, regulatory agencies, and the pharmaceutical industry. It is envisioned that this educational session will be organized by a steering committee of Society members who will identify a longitudinal curriculum for the session and speakers and topics.

Ruben A. Mesa, MD

Atrium Health Wake Forest Baptist, Winston-Salem, NC

Allison A. King, MD, PhD, MPH

Division of Public Health Services, Department of Surgery, Washington University School of Medicine, Saint Louis, MO

Robert F. Sidonio, Jr., MD, MSc

Emory University, Atlanta, GA

Jeffrey D Lebensburger, DO

University of Alabama at Birmingham, Birmingham, AL

Nina Shah, MD

AstraZeneca, South San Francisco, CA

David P. Steensma, MD

Ajax Therapeutics, Cambridge, MA